The increasing demand for precise immunological research and therapeutic design has spurred significant advances in recombinant signal molecule manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using multiple expression methods, including microbial hosts, animal cell lines, and insect